Boutault et al developed a model based on changes in the complete blood count to identify a patient with unexplained cytopenia who may have a myelodysplastic syndrome (MDS). The authors are from CHU Nantes, Avicenne University Hospital, Technischen Universitat Dresden and University Hospital Leipzig
Patient selection: unexplained cytopenia
Parameters:
(1) MCV in femtoliters (tended to be higher in MCV)
(2) Ne-WX (neutrophil complexity and width of dispersion of the events measured = coefficient of variation of the light scatter around neutrophils = neutrophil dispersion relative to granularity): available on the SYSMEX XN-10 analyzer. Scores in controls ranged from 223 to 476.